Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
A hot potato: Next-generation DNA sequencing (NGS) faces mounting scrutiny over its cyber vulnerabilities. While NGS has revolutionized fields ranging from cancer diagnostics to infectious disease ...
Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...
We retrospectively reviewed 281 patients with fever of unknown origin at the First Affiliated Hospital of Nanchang University from December 2020 to February 2023. The diagnostic criteria for FUO were ...
The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
Hartwig and Ultima to continue implementation and validation of ppmSeq, the only decentralizable whole-genome solution commercially available today for monitoring of minimal residual disease (MRD) ...
The increasing development of new genetically modified organisms underscores the critical need for comprehensive safety assessments, emphasizing the significance of molecular evidence such as gene ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
Recent treatment patterns in US-based real-world patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
We enrolled 50 patients undergoing resection of newly diagnosed (n = 15) or recurrent (n = 35) GBM. CSF was collected intraoperatively via the subarachnoid space (n = 25) or lateral ventricle (n = 25) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results